Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma

doi:10.3748/wjg.v17.i12.1631

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4818)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-4) series.

Item

Count

PDF

383

HTML

4294

Figures (1-6)

Tables (1-4)

Sum=4818

Mar 28, 2011 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 28, 2011; 17(12): 1631-1641
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631

Full Size Figure Download Figure

Figure 5 Kaplan-Meier survival curves with regard to trefoil factor copy number in cholangiocarcinoma. No association between trefoil factor (TFF) copy number and survival time (week) was found for A: TFF1; B: TFF2; C: TFF3.

Citation: Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B, Limpaiboon T. Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol 2011; 17(12): 1631-1641
URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1631.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1631